PharmaVoice Logo

Healthcare Leaders Hub

Epicrispr, Vaderis secure pivotal study funding for rare disease assets

Pharma Tech

Epicrispr, Vaderis secure pivotal study funding for rare disease assets

Epicrispr and Vaderis have secured $90m and $152m, respectively, to take their rare disease drugs to pivotal clinical development.

Read Full Article
India’s pharma exports rise 6.8% to $8.1 billion in Q1 FY27

Express Pharma

India’s pharma exports rise 6.8% to $8.1 billion in Q1 FY27

Pharmexcil data shows growth across formulations, bulk drugs, vaccines and surgical products, with the US remaining the largest export destination The post India’s pharma exports rise 6.8% to $8.1 billion in Q1 FY27 appeared first on Express Pharma.

Read Full Article
Mereo BioPharma and Sentynl Therapeutics sign licensing deal for alvelestat

Pharma Tech

Mereo BioPharma and Sentynl Therapeutics sign licensing deal for alvelestat

Mereo BioPharma and Sentynl Therapeutics have signed an option and licence agreement related to the US commercial and worldwide manufacturing rights to alvelestat, a potential oral treatment for AATD-LD.

Read Full Article
Alfasigma signs agreement to acquire Nordic Group

Pharma Tech

Alfasigma signs agreement to acquire Nordic Group

Alfasigma is to buy Nordic Group, which aims to strengthen its speciality care business and expand its reach in Europe, Canada, and Japan.

Read Full Article
Inside Shilpa Medicare’s growth strategy: Quality, digital and global ambitions

Express Pharma

Inside Shilpa Medicare’s growth strategy: Quality, digital and global ambitions

Dr Vellaian Karuppiah, COO-Management, Shilpa Medicare shares his vision for building a future-ready organisation powered by quality, digital transformation, and operational excellence. In this conversation, he discusses leadership, biosimilars, global markets, and what it takes to earn lasting regulatory trust, in an exclusive interaction with Lakshmipriya Nair The post Inside Shilpa Medicare’s growth strategy: Quality, digital and global ambitions appeared first on Express Pharma.

Read Full Article

Sponsored content

Featured promotional

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer

News

Latest stories

Pharma Tech

Aug 12, 2026, 10:04 AM

Epicrispr, Vaderis secure pivotal study funding for rare disease assets

Epicrispr and Vaderis have secured $90m and $152m, respectively, to take their rare disease drugs to pivotal clinical development.

Express Pharma

Aug 12, 2026, 9:24 AM

India’s pharma exports rise 6.8% to $8.1 billion in Q1 FY27

Pharmexcil data shows growth across formulations, bulk drugs, vaccines and surgical products, with the US remaining the largest export destination The post India’s pharma exports rise 6.8% to $8.1 billion in Q1 FY27 appeared first on Express Pharma.

Pharma Tech

Aug 12, 2026, 9:14 AM

Mereo BioPharma and Sentynl Therapeutics sign licensing deal for alvelestat

Mereo BioPharma and Sentynl Therapeutics have signed an option and licence agreement related to the US commercial and worldwide manufacturing rights to alvelestat, a potential oral treatment for AATD-LD.

PharmaShots

Aug 12, 2026, 8:30 AM

Belite Bio Receives the US FDA Priority Review for Tinlarebant to Treat Stargardt Disease Type 1

Shots: Ref:  Globenewswire  |  Image: Belite Bio  |  Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Belite Bio Receives the US FDA Priority Review for Tinlarebant to Treat Stargardt Disease Type 1 appeared first on PharmaShots.

ET Pharma

Aug 12, 2026, 8:21 AM

Pharma exports top $8 Bn in Q1 on continued momentum in Formulations, Vaccine upswing

Amid growing price erosion in the US market, regions such as Europe and Latin America, particularly Brazil, have emerged as strong growth drivers, posting double-digit growth and expected to sustain this pace in the coming quarters.

Pharma Tech

Aug 12, 2026, 8:20 AM

Alfasigma signs agreement to acquire Nordic Group

Alfasigma is to buy Nordic Group, which aims to strengthen its speciality care business and expand its reach in Europe, Canada, and Japan.

News

Latest industry coverage

Google News

Aug 12, 2026, 9:59 AM

Apotex Announces First Quarter 2027 Results - PR Newswire Canada

Apotex Announces First Quarter 2027 Results  PR Newswire Canada

Google News

Aug 12, 2026, 9:49 AM

LOT Cargo secures IATA CEIV Pharma recertification - Aviation Business News

LOT Cargo secures IATA CEIV Pharma recertification  Aviation Business News

Google News

Aug 12, 2026, 9:35 AM

Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide - reuters.com

Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide  reuters.com

Google News

Aug 12, 2026, 9:11 AM

India pharma exports rise 6.8% to $8.1 billion in Q1 FY27; vaccine shipments jump 36% - BusinessLine

India pharma exports rise 6.8% to $8.1 billion in Q1 FY27; vaccine shipments jump 36%  BusinessLine

Google News

Aug 12, 2026, 9:03 AM

Pacer Advisors Inc. Sells 484,736 Shares of Teva Pharmaceutical Industries Ltd. $TEVA - MarketBeat

Pacer Advisors Inc. Sells 484,736 Shares of Teva Pharmaceutical Industries Ltd. $TEVA  MarketBeat

Google News

Aug 12, 2026, 8:53 AM

Top 10: Pharmaceuticals Companies in UK & Ireland - Healthcare Digital

Top 10: Pharmaceuticals Companies in UK & Ireland  Healthcare Digital

Google News

Aug 12, 2026, 8:24 AM

Alfasigma signs agreement to acquire Nordic Group - Pharmaceutical Technology

Alfasigma signs agreement to acquire Nordic Group  Pharmaceutical Technology

Google News

Aug 12, 2026, 8:18 AM

Inline Camera Inspection System Market for Food & Beverage and Pharmaceutical Industries by Component - Global Forecast to 2032 - Yahoo Finance

Inline Camera Inspection System Market for Food & Beverage and Pharmaceutical Industries by Component - Global Forecast to 2032  Yahoo Finance

Google News

Aug 12, 2026, 8:17 AM

The Netherlands: Alfasigma expanding specialty care portfolio and presence in Europe with acquisition of Nordic Group BV - Investors in Healthcare

The Netherlands: Alfasigma expanding specialty care portfolio and presence in Europe with acquisition of Nordic Group BV  Investors in Healthcare

Sponsored placement

Featured promotions

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer